Log In
BCIQ
Print this Print this
 

Carticel

  Manage Alerts
Collapse Summary General Information
Company Vericel Corp.
DescriptionAutologous cultured chondrocytes
Molecular Target Not available
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentMarketed
Standard IndicationCartilage repair
Indication DetailsRepair cartilaginous defects of the femoral condyle in patients who have failed other cartilage repair procedures; Repair damaged cartilage on the femoral condyle; Repair knee cartilage damage; Repair knee damage; Treat cartilage damage of the knee; Treat cartilage defects of the femoral condyle (in the knee)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$6.5M

$4.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/21/2014

$6.5M

$4.0M

0

Get a free BioCentury trial today